Kunitama M, Komatsu N, Miura Y
Department of Medicine, Jichi Medical School.
Rinsho Ketsueki. 1996 Nov;37(11):1314-7.
The inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme-A (HMG-CoA) reductase, pravastatin and simvastatin, are widely used clinically as anti-hypercholesterolemic drugs. To determine whether these drugs affect hematopoiesis, we examined the effect of the drugs on colony formation by human bone marrow cells. Simvastatin strongly inhibited both erythroid and granulocyte-macrophage colony formation by total or CD34-positive bone marrow cells at the concentration of 10 microM, which is about 100-1,000 fold higher than the pharmacologically effective level. On the other hand, the inhibitory effect of pravastatin was much weaker than that of simvastatin. These findings show that these drugs, especially pravastatin have little effect on hematopoiesis.
3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶抑制剂普伐他汀和辛伐他汀在临床上被广泛用作抗高胆固醇血症药物。为了确定这些药物是否影响造血作用,我们检测了它们对人骨髓细胞集落形成的影响。辛伐他汀在10微摩尔浓度时强烈抑制总骨髓细胞或CD34阳性骨髓细胞的红系和粒-巨噬细胞集落形成,该浓度比药理有效水平高约100-1000倍。另一方面,普伐他汀的抑制作用比辛伐他汀弱得多。这些发现表明这些药物,尤其是普伐他汀对造血作用几乎没有影响。